Neutrophils during SARS‐CoV ‐2 infection: Friend or foe?
Immunological Reviews · 2023-03 · 314 (1) · 399-412
DOI: 10.1111/imr.13175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 28.11.2022. Verfasst von Fernanda V S Castanheira und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: COVID-19, Extracellular Traps. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID‐19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and has resulted in more than 6 million deaths worldwide. COVID‐19 is a respiratory disease characterized by pulmonary dysfunction leading to acute respiratory distress syndrome (ARDs), as well as disseminated coagulation, and multi‐organ dysfunction. Neutrophils and neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of COVID‐19. In this review, we highlight key gaps in knowledge, discuss the heterogeneity of neutrophils during the evolution of the disease, how they can contribute to COVID‐19 pathogenesis, and potential therapeutic strategies that target neutrophil‐mediated inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
- Department of Microbiology, Immunology and Infectious, University of Calgary, Calgary, Alberta, Canada.
- Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Paul Kubes
Förderung
- CIHR
- Canadian Institutes of Health Research
- Heart and Stroke Foundation of Canada
Zitieren
APA
Castanheira, F. V. S., & Kubes, P. (2023). Neutrophils during SARS‐CoV ‐2 infection: Friend or foe?. Immunological Reviews, 314(1), 399-412. https://doi.org/10.1111/imr.13175
Vancouver
Castanheira FVS, Kubes P. Neutrophils during SARS‐CoV ‐2 infection: Friend or foe?. Immunological Reviews. 2023;314(1):399-412. doi:10.1111/imr.13175
BibTeX
@article{Castanheira2023,
author = {Castanheira, Fernanda V S and Kubes, Paul},
title = {Neutrophils during SARS‐CoV ‐2 infection: Friend or foe?},
journal = {Immunological Reviews},
year = {2023},
volume = {314},
number = {1},
pages = {399--412},
doi = {10.1111/imr.13175}
}
EUVIMED